Authors

Verena Bertram

Salary Partner

Read More

Dr. Anja Lunze, LL.M.

Partner

Read More
Authors

Verena Bertram

Salary Partner

Read More

Dr. Anja Lunze, LL.M.

Partner

Read More

1 December 2019

Manufacturing and stockpiling waiver for EU-based generic and biosimilar manufacturers – 2 of 3 Insights

SPC manufacturing waiver (Part 2): The fairy tale of day-1 entry under the manufacturing and stockpiling waiver – a German view

Call To Action Arrow Image

Latest insights in your inbox

Subscribe to newsletters on topics relevant to you.

Subscribe
Subscribe

Related Insights

Patents & innovation

Marketing authorisation and clinical testing of new drugs

15 April 2020

by Dr. Anja Lunze, LL.M. and Dr. Jan Phillip Rektorschek

Click here to find out more
Patents & innovation

Restrictions for patents owners to preserve the public interest in the sufficient availability of necessary medicinal products

7 April 2020

by Dr. Anja Lunze, LL.M. and Dr. Jan Phillip Rektorschek

Click here to find out more
Life sciences & healthcare

No compulsory licence for Sanofi's Praluent in Germany

30 June 2019
Briefing

by Dr. Anja Lunze, LL.M.

Click here to find out more